Latest News
Syncona investment Autolus confirms Nasdaq float plans
Cancer-focused biopharmaceutical company Autolus, in which FTSE 250 healthcare investment firm Syncona has a 38% stake, has filed for an initial public offering on the New York stock exchange.
RHI Magnesita reports positive first-quarter trading
RHI Magnesita reported positive trading in the first quarter as rising prices more than made up for higher raw materials costs for the industrial products supplier.
BGEO recognised for work with women-owned businesses
BGEO Group was celebrating on Tuesday, after its banking business subsidiary JSC Bank of Georgia was recognised as the ‘Best Issuing Bank Partner for Women-Owned Businesses in Europe and Central Asia’ for 2017, by International Finance Corporation's Global Trade Finance Programme (GTFP), in cooperation with the Banking on Women Programme.
Centrica chairman Haythornthwaite to step down
Centrica's chairman, Rick Haythornthwaite, is planning to step down within the next 12 months after six years in the role, the energy provider said on Tuesday.
FirstGroup tumbles as Apollo walks away
FirstGroup shares tumbled on Tuesday after private equity group Apollo Management said it would not be making an offer for the transport operator.
US pre-open: Stocks to nudge lower ahead of Trump's Iran announcement
US futures pointed to a slightly weaker open on Wall Street on Tuesday as investors eyed an announcement by US President Trump over the Iran nuclear deal.
Europe open: Stocks skid ahead of Iran announcement, Italian shares heavily sold
Stocks have started the morning trading lower ahead of the expected announcement by the US administration of its decision regarding the multilateral nuclear deal with Iran later in the day.
4d Pharma submits new IBS drug application to FDA
AIM-quoted pharmaceutical company 4d Pharma has submitted an investigational new drug application for Blautix, its live biotherapeutic for the treatment of irritable bowel syndrome, to the US Food and Drug Administration.
Frontera moves ahead with Georgian operations
AIM-quoted oil and gas explorer Frontera Resources issued an update on its Georgian operations at the Tarbani Complex on Tuesday.
Greencoat UK Wind to increase stake in Scottish wind farm
FTSE 250 renewable infrastructure fund Greencoat UK Wind will increase its stake in Scotland's Clyde wind farms to 28. 2% for a consideration of £114. 2m.
SDX Energy shares jump after Moroccan gas discovery
Oil and gas developer SDX Energy has made a conventional natural gas discovery in Morocco and spudded a new exploration well in Egypt.
Ideagen revenue surges 33%, management reshuffle announced
AIM-listed Ideagen named its new chief executive officer on Tuesday as it said it expects to report a 33% jump in full-year revenue.
UK house price growth unexpectedly eases in April - Halifax
UK house price growth unexpectedly eased in April, according to data from lender Halifax.
Comcast commits to Sky News, mulls fresh bid for Fox assets
Comcast pledged to operate Sky's news arm for at least five years if its offer for the broadcaster was successful as the US company was reported to be preparing an attempt to gatecrash Disney's purchase of assets from 21st Century Fox.
William Hill enjoys 'unprecedented' sports results, awaits key regulation
Bookmaker William Hill hailed strong online and US performances as net revenues rose 3% in the first 17 weeks of the year, putting rivals' results rather in the shade.
PureCircle welcomes New Zealand launch of Coca-Cola Stevia
Stevia ingredients producer PureCircle confirmed the launch of ‘Coca-Cola Stevia No Sugar’ in New Zealand on Tuesday - said to be the first Coca-Cola product globally to be sweetened solely with stevia.
OptiBiotix to show off new products and data at Swiss industry event
Life sciences firm OptiBiotix Health announced on Tuesday that it will display brand new products and research data at the Vitafoods European tradeshow in Geneva from 15 to 17 May.
Costain wins contract with Highways England, says current trading in line
Costain said on Tuesday that it had been awarded a technology contract by Highways England, and confirmed that current trading is in line with expectations.
Faron Pharmaceuticals crashes on results of disappointing study
Faron Pharmaceuticals shares plummeted 85% in early trade on Tuesday as it reported widening annual losses and disappointing results from a respiratory drug trial.
Hiscox sees slower growth after strong first quarter
Hiscox’s gross written premiums rose by a fifth in the first quarter but the insurer warned of slower growth ahead as competitors pile into the market.